The Depression Screening Market is becoming a vital part of the healthcare industry as mental health takes center stage in global health priorities. Depression affects more than 280 million people worldwide, making it a leading cause of disability. Early diagnosis through screening is essential to prevent severe consequences, including suicide.

The market is expanding due to increasing mental health awareness, government initiatives, and technological innovations. Screening is now integrated into primary healthcare, schools, workplaces, and telehealth platforms. Tools range from traditional paper-based questionnaires to AI-powered apps and wearable devices that track mood patterns.

North America leads in adoption due to strong healthcare infrastructure and mental health policies, while Asia-Pacific is the fastest-growing region thanks to improving awareness and digital healthcare investments. Despite growth, challenges like stigma, shortage of mental health professionals, and inconsistent reimbursement policies remain.

With ongoing innovation and policy support, the depression screening market is poised for substantial growth, becoming an integral part of preventive and community healthcare strategies.